Faculty Profile - UB School of Medicine and Biomedical Sciences

Zeremski M, Makeyeva J, Arasteh K, Des Jarlais DC, Talal AH. Hepatitis C virus-specific immune responses in noninjecting drug users. J Viral Hepat. 2012; 19(8).

Talal AH, Dimova RB, Seewald R, Peterson RH, Zeremski M, Perlman DC, Des Jarlais DC. Assessment of methadone clinic staff attitudes toward hepatitis C evaluation and treatment. J Subst Abuse Treat. 2012.

Martinez AD, Dimova R, Marks KM, Beeder AB, Zeremski M, Kreek MJ, Talal AH. Integrated addiction medicine – Hepatology model for hepatitis C management for individuals on methadone maintenance. (in press). Journal of Viral Hepatology. 2012.

Talal AH, Liu RC, Zeremski M, Dimova R, Dove L, Pearce D, Hassanein T, Doonquah L, Aboulafia D, Rodriguez J, Bonilla H, Galpin J, Aberg JA, Johnston B, Glesby MJ, Jacobson IM. Randomized trial comparing dose reduction and growth factor supplementation for management of hematological side effects in HIV/hepatitis C virus patients receiving pegylated-interferon and ribavirin J Acquir Immune Defic Syndr. 2011; 58(3).

Zeremski M, Hooker G, Shu MA, Winkelstein E, Brown Q, Des Jarlais DC, Tobler LH, Rehermann B, Busch MP, Edlin BR, Talal AH. Induction of CXCR3- and CCR5-associated chemokines during acute hepatitis C virus infection. J Hepatol. 2011; 55(3).

Chak E, Talal AH, Sherman KE, Schiff ER, Saab S. Hepatitis C virus infection in USA: an estimate of true prevalence. Liver Int. 2011; 31(8).

Talal AH, Liu RC, Zeremski M, Dimova R, Dove L, Pearce D, Hassanein T, Doonquah L, Aboulafia D, Rodriguez j, Bonilla H, Galpin J, Aberg Ja, Johnston B, Glesby MJ, Jacobson IM. Randomized Trial Comparing Dose Reduction and Growth Factor Supplementation for Management of Hematological Side Effects in HIV/HCV Patients Receiving Pegylated-Interferon and Ribavirin... Acquired Immune Deficiency Syndrome. 2011; 58.

Chak E, Talal AH, Sherman K, Saab S. Hepatitis C Virus Infection In The United States: An Estimate Of True Prevalence.. Liver International. 2011; 31.

Dimova R, Markatou M, Talal AH. A Comparison of Information Methods for Model Selection in Mixed Effects Models with Application to data from Hepatitis C Virus Infection.. Computational Statistics and Data Analysis. 2011; 55.

Hudacko RM, Alvarez GA, Talal AH, Jacobson I, Wan DW, Zhou XK, Yantiss RK. Clinical and biologic importance of F-actin autoantibodies in HCV monoinfected and HCV-HIV coinfected patients. Am J Clin Pathol. 2010; 134(2).

Vachon M-LC, Factor SH, Branch AD, Fiel MI, Rodriguez-Torres M, Bräu N, Sterling RK, Slim J, Talal AH, Dieterich DT, Sulkowski MS. Insulin resistance predicts retreatment failure in an efficacy study of peginterferon-a-2a and ribavirin in HIV/HCV co-infected patients. Journal of Hepatology. 2010; 54.

Talal AH. Substance Use and Dependence among Patients in an Academic Hepatology Clinic.. Digestive and Liver Disease. 2010; 42.

Hudacko RM, Alvarez GA, Talal AH, Jacobson IM, Wan DX, Zhou XK, Yantiss RK. Clinical and pathological importance of elevated serum F-actin autoantibodies in HCV mono-infected and HCV/HIV co-infected patients.. American Journal of Clinical Pathology. 2010; 134.

Gonzalez SA, Fiel MI, Sauk J, Canchis PW, Liu RC, Chiriboga L, Yee HT, Jacobson IM, Talal AH. Inverse association between hepatic stellate cell apoptosis and fibrosis in chronic hepatitis C virus infection. J Viral Hepat. 2009; 16(2).

Marks KM, Clarke RMA, Bussel JB, Talal AH, Glesby MJ. Risk Factors for Thrombocytopenia in HIV-infected Persons in the Era of Potent Antiretroviral Therapy.. Journal of Acquired Immune Deficiency Syndrome. 2009; 52.

Zeremski M, Dimova R, Brown QB, Jacobson IM, Markatou, Talal AH. Peripheral CXCR3-associated chemokines as Biomarkers of Fibrosis in Chronic Hepatitis C Virus Infection. Journal of Infectious Diseases. 2009; 200.

Wan D, Marks KM, Yantiss RK, Talal AH. Importance of Autoimmune Hepatitis in HIV/HCV Coinfection. AIDS Patient Care and STDs. 2009; 23.

Zeremski M, Shu M, Brown QB, Wu Y, Des Jarlais DC, Busch MP, Talal AH, Edlin BR. HCV-Specific T Cell Immune Responses In Seronegative Injection Drug Users. Journal of Viral Hepatology. 2009; 16.

Zeremski M, Petrovic LM, Chiriboga L, Brown QB, Yee HT, Kinkhabwala M, Jacobson IM, Dimova R, Markatou M, Talal AH. Intrahepatic levels of CXCR3-associated chemokines correlate with liver inflammation and fibrosis in chronic hepatitis C. Hepatology. 2008; 48(5).

Charles ED, Green RM, Marukian S, Talal AH, Lake-Bakaar GV, Jacobson IM, Rice CM, Dustin LB. Clonal expansion of immunoglobulin M+CD27+ B cells in HCV-associated mixed cryoglobulinemia. Blood. 2008; 111(3).

Gonzalez SA, Zhang C, Fiel MI, Chung S, Zhang L, Jacobson IM, Talal AH. Hepatic Inflammatory Cytokine mRNA Expression in Hepatitis C Virus-Human Immunodeficiency Virus Co-infection. Journal of Viral Hepatology. 2008; 15.

Cheruvu S, Marks K, Talal AH. Understanding the pathogenesis and management of hepatitis B/HIV and hepatitis B/hepatitis C virus coinfection. Clin Liver Dis. 2007; 11(4).

Zeremski M, Talal AH. Hepatitis C viral kinetics during treatment of hepatitis C virus/HIV coinfected patients. Curr Opin HIV AIDS. 2007; 2(6).

Zeremski M, Petrovic LM, Talal AH. The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection. J Viral Hepat. 2007; 14(10).

Kadam JS, Talal AH. Changing treatment paradigms: hepatitis C virus in HIV-infected patients. AIDS Patient Care STDS. 2007; 21(3).

Gonzalez SA, Liu RC, Edlin BR, Jacobson IM, Talal AH. HIV/hepatitis C virus-coinfected patients with normal alanine aminotransferase levels. Journal of Acquired Immune Deficiency Syndromes. 2006; 41.

Longman RS, Talal AH, Jacobson IM, Rice CM, Albert ML. Normal functional capacity in circulating myeloid and plasmacytoid dendritic cells in patients with chronic hepatitis C. J Infect Dis. 2005; 192(3).

Butera D, Marukian S, Iwamaye AE, Hembrador E, Chambers TJ, Di Bisceglie AM, Charles ED, Talal AH, Jacobson IM, Rice CM, Dustin LB. Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C. Blood. 2005; 106(4).

Marks KM, Petrovic LM, Talal AH, Murray MP, Gulick RM, Glesby MJ. Histologic findings and clinical characteristic associated with steatosis in patients coinfected with HIV and hepatitis C virus. Journal of Infectious Diseases. 2005; 192.

Lin AW, Gonzalez SA, Cunningham-Rundles S, Dorante G, Marshall S, Tignor A, Ha C, Jacobson IM, Talal AH. CD56(+dim) and CD56(+bright) cell activation and apoptosis in hepatitis C virus infection. Clin Exp Immunol. 2004; 137(2).

Wilfredo Canchis P, Gonzalez SA, Isabel Fiel M, Chiriboga L, Yee H, Edlin BR, Jacobson IM, Talal AH. Hepatocyte proliferation in chronic hepatitis C: correlation with degree of liver disease and serum alpha-fetoprotein. Liver Int. 2004; 24(3).

Talal AH, Shata MT, Markatou M, Dorante G, Chadburn A, Koch R, Neumann AU, Ribeiro RM, Perelson AS. Virus dynamics and immune responses during treatment in patients coinfected with hepatitis C and HIV. J Acquir Immune Defic Syndr. 2004; 35(2).

Logvinoff C, Major ME, Oldach D, Heyward S, Talal AH, Balfe P, Feinstone SM, Alter H, Rice CM, McKeating JA. Neutralizing antibody response during acute and chronic hepatitis C virus infection. Proceedings of the National Academy of Sciences of the USA. 2004; 101.

Canchis PW, Yee HT, Fiel MI, Dieterich DT, Liu R-C, Chiriboga L, Jacobson IM, Edlin BR, Talal AH. Intrahepatic CD4 cell depletion in hepatitis C virus/HIV-coinfected patients. Journal of Acquired Immune Deficiency Syndrome. 2004; 37.

Gonzalez SA, Talal AH. Hepatitis C virus in human immunodeficiency virus-infected individuals: an emerging comorbidity with significant implications. Semin Liver Dis. 2003; 23(2).

Ni J, Hembrador E, Di Bisceglie AM, Jacobson IM, Talal AH, Butera D, Rice CM, Chambers TJ, Dustin LB. Accumulation of B lymphocytes with a naive, resting phenotype in a subset of hepatitis C patients. J Immunol. 2003; 170(6).

Talal AH, Canchis PW, Jacobson I. The HCV and HIV coinfected patient: what have we learned about pathophysiology? Curr Gastroenterol Rep. 2002; 4(1).

Talal AH, Weisz K, Hau T, Kreiswirth S, Dieterich DT. A preliminary study of erythropoietin for anemia associated with ribavirin and interferon-alfa. American Journal of Gastroenterolgy. 2001; 96.

Talal AH, Moe CL, Lima AA, Weigle KA, Barrett, Bangdiwala SI, Estes MK, Guerrant RL. Seroprevalence and seroincidence of Norwalk-like virus infection among Brazilian infants and children.. Journal of Medical Virology. 2000; (61).

Parks CG, Moe CL, Rhodes D, Lima A, Barrett L, Tseng F, Baric R, Talal AH, Guerrant R. Genomic diversity of “Norwalk like viruses” (NLVs): pediatric infections in a Brazilian shantytown.. Journal of Medical Virology. 1999; 58.

Zhang L, Ramratnam B, Tenner-Racz K, He Y, Vesanen M, Lewin S, Talal AH, Racz P, Perelson AS, Korber BT, Markowitz M, Ho DD. Quantifying residual HIV-1 replication in patients receiving combination antiretroviral therapy.. New Eng J Med. 1999; 340.

Talal AH, Kotler DP, Orenstein JM, Weiss LM. Detection of Enterocytozoon bieneusi in fecal specimens by polymerase chain reaction analysis with primers to the small-subunit rRNA. Clin Infect Dis. 1998; 26(3).

Zhang L., He T., Talal AH, Wang G., Frankel SS., Ho DD.. In vivo distribution of the human immunodeficiency virus/simian immunodeficiency virus co-receptors: CXCR4, CCR3, and CCR5.. Virol. 1998; 72.

Talal AH, Murray JA, Goeken JA, Sivitz WI. Celiac disease in an adult population with insulin-dependent diabetes mellitus: use of endomysial antibody testing. Am J Gastroenterol. 1997; 92(8).

Talal AH, Weiss LM, Vanderhorst C. Molecular diagnosis of gastrointestinal infections associated with HIV infection Gastroenterol Clin North Am. 1997; 26(2).

Talal AH, Murray J.A., Goeken J.A., Sivitz W.I.. Celiac Disease in an Adult Population with Insulin Dependent Diabetes Mellitus: Use of Endomysial Antibody Testing. American Journal of Gastroenterology. 1997; 92.

Talal AH, Murray JA. Acute and chronic diarrhea. How to keep laboratory testing to a minimum Postgrad Med. 1994; 96(3).

Skopuli F.N., Talal AH, Galanopoulou V., Tsampoulas C.G., Drosos A.A., Moutsopoulos H.M.. Raynaud's phenomenon in primary Sjogren’s syndrome. Rheumatology. 1990; 17.

Andrew H. Talal MD

Specialty/Research Focus

Education and Training:

Employment:

Awards and Honors:

Research Expertise:

Grants and Sponsored Research:

Evaluative Studies and Case Reports:

Journal Articles:

Professional Memberships:

Presentations:

Service Activities:

Clinical Specialties:

Clinical Offices:

Insurance Accepted:

Contact Information

Patient Care

School of Medicine and Biomedical Sciences

Join the School

Get Involved

Find People

Connect with Us

About The School

Centers and Affiliations

Education and Training

Research Facilities and Services

Health Care

Resources by Audience

Alumni

Governance

Learning Resources

Support Services

Site Tools